AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published its 2024 Annual Results announcement on March 30, ...

Merck signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion.

New study results presented at the European Lung Cancer Congress (ELCC) 2025, 26 to 29 March, demonstrate the role of AstraZeneca’s Tagrisso (osimertinib), as monotherapy and as the backbone for novel ...

(" Kelun-Biotech " or the " Company ", Stock Code: 6990.HK) announced its audited consolidated results for the year ended December 31, 2024 (the " Reporting Period "). In 2024, the pharmaceutical and ...

The world’s first approved antibody-drug conjugate, where a targeted antibody ... looks set to change rapidly in the coming years, thanks to a wave of innovation including CAR-T and other ...

Some examples include better sky coverage by use of laser 'guide stars' (reference beacons stimulated in the upper atmosphere), an enhanced field of view by multi-conjugate tomographic techniques ...

Join hosts Emily Kwong and Regina Barber for science on a different wavelength. If you're hooked, try Short Wave Plus. Your subscription supports the show and unlocks a sponsor-free feed.

End-to-end investment management platform Dynamo Software today announced that its portfolio management software (PMS) took the top spot in the Best Portfolio Management System category of the Fund ...

It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate that is in Phase I clinical trial for the treatment of myelodysplastic syndromes, refractory/relapsed acute ...

Ping An Healthcare and Technology Company Limited (" Ping An Good Doctor ", "Ping An Health" or "the Company", Stock Code: 1833.HK) recently released its 2024 Environmental, Social, and Governance ...

The Exotic Mission Rotator returns in Episode Heresy, with the fan-favorite weekly activity avoiding the content vault. Here’s everything you need to know about the Exotic Mission Rotator in ...